SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-123821
Filing Date
2016-05-27
Accepted
2016-05-27 08:15:45
Documents
3
Period of Report
2016-05-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-12358_18k.htm 8-K 60233
2 EX-3.1 a16-12358_1ex3d1.htm EX-3.1 1087
3 GRAPHIC g123581kgi001.gif GRAPHIC 175848
  Complete submission text file 0001104659-16-123821.txt   304902
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 161680010
SIC: 3841 Surgical & Medical Instruments & Apparatus